This Guidelines stipulates the principle, definition, and primary technical parameters of microarrays when applying to safety and efficacy evaluation of pharmaceutical products, as well as the requirements of test sample, the preparation of graphs, and analysis methods. The purpose is to standardize microarray-based pharmaceutical products’ safety and efficacy evaluations and provide instructions on fundamental requirements for experiment design, methodology establishment and adaptability of determination methods.